Work

Ianalumab retreatment in adults with primary immune thrombocytopenia (ITP) or warm-antibody autoimmune hemolytic anemia (wAIHA) who benefitted from previous ianalumab treatment: A phase 2 exploratory study

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-6586

Authors: Francesco Zaja, Adam Cuker, Hanny Al-Samkari, Marc Michel, Yogesh Chattar, Matthew Foster, Meritxell Vendranas, Nicola Cooper

Institutions: Azienda sanitaria universitaria Giuliano Isontina, University of Pennsylvania, Harvard University, Massachusetts General Hospital, Université Paris-Est Créteil, Assistance Publique – Hôpitaux de Paris, Hôpitaux Universitaires Henri-Mondor, Novartis (India), Novartis (Spain), Hammersmith Hospital

Language: English

Topic: Platelet Disorders and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417009874

Cites:

Cited by:

Related to: